- Location
Sandoz
"-
Sandoz Canada Has Recalled Its Health Product Glimepiride Over The Mislabeling of Boxes
Feb 10, 2014Sandoz Canada has recalled its health product glimepiride, which is used to treat diabetes, over the mislabeling of boxes. The mislabeling has occurred on outer carton of the product, which shows as containing 1mg tablets, while the ...
Tags: Glimepiride Medicines, Medicines
-
INSV Has Reported The US District Court Upheld All Four of The Patents Protecting AzaSite
Oct 10, 2013InSite Vision Incorporated (INSV) has reported that the US District Court for the District of New Jersey upheld all four of the patents protecting AzaSite, an azithromycin 1% ophthalmic solution, in a patent infringement lawsuit against ...
-
SK Capital Is Expected to Close The Acquisition of The Textile Chemicals
Sep 18, 2013SK Capital, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, is expected to close the acquisition of the Textile Chemicals, Paper Specialties and Emulsions businesses from ...
Tags: specialty materials, Textile
-
FDA Laid out The Kind of Scientific Studies Generic Companies Need to Submit
Sep 12, 2013One of the world's top-selling drugs—GlaxoSmithKline PLC's $8-billion-a-year asthma treatment Advair—became more vulnerable to generic competition after the U.S. Food and Drug Administration issued guidance on the regulatory ...
-
National Phase Approvals to Apricus Biosciences's Vitaros
Aug 20, 2013The Irish Medicines Board and the Netherlands' Medicines Evaluations Board have granted national phase approvals to Apricus Biosciences' Vitaros, indicated to treat patients with erectile dysfunction (ED). Vitaros now has four national ...
Tags: Apricus Bio, Medicine
-
Avanir Pharmaceuticals Has Settled Pending Patent Litigation
Aug 19, 2013Avanir Pharmaceuticals has settled pending patent litigation concerning Sandoz's abbreviated new drug application (ANDA) to market generic versions of Avanir's Nuedexta (dextromethorphan hydrobromide/quinidine sulfate) capsules. Under the ...
Tags: Avanir Pharmaceuticals
-
The US District Court Ruled in Favor of Teva Pharmaceutical Industries
Dec 6, 2012The US District Court for the Southern District of New York has ruled in favor of Teva Pharmaceutical Industries in Copaxone patent infringement litigation. Teva filed lawsuit against Momenta/Sandoz and Mylan/Natco for infringement of ...
Tags: patent, Teva Pharmaceutical Industries, FDA
-
FTC Approval for Its Acquisition of The Actavis Group of Companies
Dec 4, 2012Watson Pharmaceuticals has received the US Federal Trade Commission (FTC) approval for its acquisition of the Actavis group of companies. The approval is the result of Watson's agreement to a proposed consent order to divest certain ...
